Skip to content

Insider · CIK 0000902453

Christer Rosen

ceochairofficerdirectorowner

Files at JUNS (JUPITER NEUROSCIENCES, INC.). First filing Jul 1, 2025, latest Jul 3, 2025.

Christer Rosen files SEC Form 4 as CEO, chair, director and 10% owner at JUNS (JUPITER NEUROSCIENCES, INC.). Since Jul 1, 2025, Christer Rosen has reported 2 open-market buys worth $12k and 0 open-market sells worth $0, the latest filed on Jul 3, 2025.

A track record needs three past buys with six months of prices behind them; Christer Rosen has 0, so none is measured yet.

The newest scored trade: bought $3,667 of JUNS on Jul 1, 2025, filed Jul 3, 2025, scored 33 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$12k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

JUNS: JUPITER NEUROSCIENCES, INC.

JUNSOct 9, 2026 · close 2.85

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
33Weak
JUNSbuy 2
JUPITER NEUROSCIENCES, INC.
$3,667
3,600 shares
+0%-
28Weak
JUNSbuy 2
JUPITER NEUROSCIENCES, INC.
$7,986
7,816 shares
+0%-

Transactions

Every row this insider has filed, 12 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 2, 2026JUNS
JUPITER NEUROSCIENCES, INC.
AGrant or award
Stock Optionderivative
+747,783$0.00$0747,783Jun 4, 2026
Jul 1, 2025JUNS
JUPITER NEUROSCIENCES, INC.
POpen-market purchase
Common Stock
+500$1.01$50511,075,792Jul 3, 2025
Jul 1, 2025JUNS
JUPITER NEUROSCIENCES, INC.
POpen-market purchase
Common Stock
+3,100$1.02$3,16211,078,892Jul 3, 2025
Jun 2, 2025JUNS
JUPITER NEUROSCIENCES, INC.
MOption exercise
Common Stock
+497,396$0.00$010,591,406Jul 1, 2025
Jun 2, 2025JUNS
JUPITER NEUROSCIENCES, INC.
MOption exercise
Common Stock
+476,070$0.00$011,067,476Jul 1, 2025
Jun 27, 2025JUNS
JUPITER NEUROSCIENCES, INC.
POpen-market purchase
Common Stock
+166$1.06$17611,067,642Jul 1, 2025
Jun 30, 2025JUNS
JUPITER NEUROSCIENCES, INC.
POpen-market purchase
Common Stock
+1,000$0.98$98011,068,642Jul 1, 2025
Jun 30, 2025JUNS
JUPITER NEUROSCIENCES, INC.
POpen-market purchase
Common Stock
+2,000$1.01$2,02011,070,642Jul 1, 2025
Jun 30, 2025JUNS
JUPITER NEUROSCIENCES, INC.
POpen-market purchase
Common Stock
+1,450$1.02$1,47911,072,092Jul 1, 2025
Jun 30, 2025JUNS
JUPITER NEUROSCIENCES, INC.
POpen-market purchase
Common Stock
+700$1.03$72111,072,792Jul 1, 2025
Jun 30, 2025JUNS
JUPITER NEUROSCIENCES, INC.
POpen-market purchase
Common Stock
+1,500$1.04$1,56011,074,292Jul 1, 2025
Jun 30, 2025JUNS
JUPITER NEUROSCIENCES, INC.
POpen-market purchase
Common Stock
+1,000$1.05$1,05011,075,292Jul 1, 2025

Questions about Christer Rosen

Answered from the filings on this page, as of the latest one.

Is Christer Rosen buying or selling?

Not in the last 12 months. Christer Rosen's latest open-market trade on SEC Form 4 was bought $3,667 of JUNS on Jul 1, 2025.

How did Christer Rosen's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christer Rosen has 0.

Where does Christer Rosen file Form 4?

Christer Rosen has filed Form 4 at JUNS (JUPITER NEUROSCIENCES, INC.) as CEO and Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Christer Rosen: insider trades and track record | InsiderTell